AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $455,000 | +56.9% | 33,471 | +10.5% | 0.17% | -52.3% |
| Q4 2018 | $290,000 | -24.7% | 30,287 | -4.8% | 0.35% | -45.9% |
| Q3 2018 | $385,000 | +31.8% | 31,810 | +70.2% | 0.65% | +39.4% |
| Q2 2018 | $292,000 | -48.6% | 18,691 | -50.5% | 0.47% | +106.6% |
| Q1 2018 | $568,000 | +15.7% | 37,773 | +10.6% | 0.23% | -5.8% |
| Q4 2017 | $491,000 | -13.9% | 34,149 | -9.6% | 0.24% | -59.0% |
| Q3 2017 | $570,000 | – | 37,773 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |